KevinJamesBielamowiczMD
Pediatric Hematology & Oncology • Little Rock, ARPediatric Neuro-Oncology
Physician
Dr. Bielamowicz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Arkansas Children's Hospital, Arkansas Children's Northwest
1 Children's Way
Little Rock, AR 72202Phone+1 501-263-2621
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2012 - 2015
University of Arkansas for Medical Sciences (UAMS) College of MedicineChief Residency, Pediatrics, 2011 - 2012- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 2008 - 2011
University of Texas Southwestern Medical SchoolClass of 2008
Certifications & Licensure
AR State Medical License 2016 - 2024
TX State Medical License 2015 - 2018- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas Start of enrollment: 2019 Sep 29
- Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children Start of enrollment: 2016 Feb 16
Roles: Principal Investigator, Contact
- HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors Start of enrollment: 2015 Sep 01
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 302 citationsTrivalent CAR T cells overcome interpatient antigenic variability in glioblastoma.Kevin Bielamowicz, Kristen Fousek, Tiara T. Byrd, Hebatalla Samaha, Malini Mukherjee
Neuro-Oncology. 2018-03-27 - 563 citationsHER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation TrialNabil Ahmed, Vita S. Brawley, Meenakshi Hegde, Kevin Bielamowicz, Mamta Kalra
JAMA Oncology. 2017-08-01 - 145 citationsLocoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymomaLaura K. Donovan, Alberto Delaidelli, Sujith K. Joseph, Kevin Bielamowicz, Kristen Fousek
Nature Medicine. 2020-04-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
